Paraneoplastic Hyperthyroidism Secondary to a ChemotherapyInduced Surge in β-hCG in a Patient with Non-Seminomatous Germ Cell Tumor
Hawai i Journal of health & Social Welfare · 2024
DOI: 10.62547/grpr1381 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hawai i Journal of health & Social Welfare, 2024. Verfasst von Lindsay A. Erol und 1 weiteren Autor:innen. Die Arbeit wurde bisher 3-mal zitiert (Crossref).
Abstract (Originalsprache)
Thyrotoxicosis as the presenting syndrome of an underlying β-hCG-secreting malignancy is well described. It has been previously theorized, but not reported, that the surge of β-hCG secondary to chemotherapy induction may inadvertently trigger thyrotoxicosis. After thorough review, this is the first documented case of such event in peer-reviewed medical literature published in the English language. This is a case of a 21-year-old male with stage IIIc non-seminomatous germ cell tumor who developed paraneoplastic hyperthyroidism within 4 days of the first cycle of chemotherapy. Management considerations are suggested based on this case and review of the literature.
Zitieren
APA
Erol, L. A., & Layman, C. P. (2024). Paraneoplastic Hyperthyroidism Secondary to a ChemotherapyInduced Surge in β-hCG in a Patient with Non-Seminomatous Germ Cell Tumor. Hawai i Journal of health & Social Welfare. https://doi.org/10.62547/grpr1381
Vancouver
Erol LA, Layman CP. Paraneoplastic Hyperthyroidism Secondary to a ChemotherapyInduced Surge in β-hCG in a Patient with Non-Seminomatous Germ Cell Tumor. Hawai i Journal of health & Social Welfare. 2024. doi:10.62547/grpr1381
BibTeX
@article{Erol2024,
author = {Erol, Lindsay A. and Layman, Clifton P.},
title = {Paraneoplastic Hyperthyroidism Secondary to a ChemotherapyInduced Surge in β-hCG in a Patient with Non-Seminomatous Germ Cell Tumor},
journal = {Hawai i Journal of health & Social Welfare},
year = {2024},
doi = {10.62547/grpr1381}
}
EUVIMED